COVESTRO AG (1COV.DE) Fundamental Analysis & Valuation

FRA:1COV • DE0006062144

Current stock price

59.98 EUR
+0.18 (+0.3%)
Last:

This 1COV.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. 1COV.DE Profitability Analysis

1.1 Basic Checks

  • In the past year 1COV has reported negative net income.
  • 1COV had a positive operating cash flow in the past year.
  • In multiple years 1COV reported negative net income over the last 5 years.
  • 1COV had a positive operating cash flow in each of the past 5 years.
1COV.DE Yearly Net Income VS EBIT VS OCF VS FCF1COV.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of -3.46%, 1COV is doing worse than 76.47% of the companies in the same industry.
  • The Return On Equity of 1COV (-7.52%) is worse than 77.94% of its industry peers.
Industry RankSector Rank
ROA -3.46%
ROE -7.52%
ROIC N/A
ROA(3y)-1.76%
ROA(5y)1.73%
ROE(3y)-3.61%
ROE(5y)3.67%
ROIC(3y)N/A
ROIC(5y)N/A
1COV.DE Yearly ROA, ROE, ROIC1COV.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

1.3 Margins

  • 1COV's Operating Margin has declined in the last couple of years.
  • With a Gross Margin value of 13.93%, 1COV is not doing good in the industry: 79.41% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of 1COV has declined.
  • The Profit Margin and Operating Margin are not available for 1COV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 13.93%
OM growth 3Y-78.51%
OM growth 5Y-54.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18%
GM growth 5Y-7.1%
1COV.DE Yearly Profit, Operating, Gross Margins1COV.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. 1COV.DE Health Analysis

2.1 Basic Checks

  • 1COV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • 1COV has about the same amout of shares outstanding than it did 1 year ago.
  • The number of shares outstanding for 1COV has been increased compared to 5 years ago.
  • 1COV has a better debt/assets ratio than last year.
1COV.DE Yearly Shares Outstanding1COV.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
1COV.DE Yearly Total Debt VS Total Assets1COV.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 2.27 indicates that 1COV is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • With a Altman-Z score value of 2.27, 1COV perfoms like the industry average, outperforming 45.59% of the companies in the same industry.
  • 1COV has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • 1COV has a Debt to Equity ratio of 0.34. This is in the better half of the industry: 1COV outperforms 60.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Altman-Z 2.27
ROIC/WACCN/A
WACC6.37%
1COV.DE Yearly LT Debt VS Equity VS FCF1COV.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 1.36 indicates that 1COV should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.36, 1COV is doing worse than 75.00% of the companies in the same industry.
  • A Quick Ratio of 0.73 indicates that 1COV may have some problems paying its short term obligations.
  • With a Quick ratio value of 0.73, 1COV is not doing good in the industry: 76.47% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.73
1COV.DE Yearly Current Assets VS Current Liabilites1COV.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. 1COV.DE Growth Analysis

3.1 Past

  • The earnings per share for 1COV have decreased strongly by -76.09% in the last year.
  • Looking at the last year, 1COV shows a decrease in Revenue. The Revenue has decreased by -5.27% in the last year.
  • Measured over the past years, 1COV shows a small growth in Revenue. The Revenue has been growing by 2.70% on average per year.
EPS 1Y (TTM)-76.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-247.06%
Revenue 1Y (TTM)-5.27%
Revenue growth 3Y-3.75%
Revenue growth 5Y2.7%
Sales Q2Q%-11.99%

3.2 Future

  • 1COV is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.37% yearly.
  • The Revenue is expected to grow by 1.10% on average over the next years.
EPS Next Y-40.99%
EPS Next 2Y53.83%
EPS Next 3Y43.15%
EPS Next 5Y20.37%
Revenue Next Year-7.78%
Revenue Next 2Y-2.6%
Revenue Next 3Y-0.49%
Revenue Next 5Y1.1%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
1COV.DE Yearly Revenue VS Estimates1COV.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
1COV.DE Yearly EPS VS Estimates1COV.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

1

4. 1COV.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • 1COV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • 1COV is valuated quite expensively with a Price/Forward Earnings ratio of 115.30.
  • Based on the Price/Forward Earnings ratio, 1COV is valued a bit more expensive than the industry average as 72.06% of the companies are valued more cheaply.
  • When comparing the Price/Forward Earnings ratio of 1COV to the average of the S&P500 Index (37.95), we can say 1COV is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 115.3
1COV.DE Price Earnings VS Forward Price Earnings1COV.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 60 80 100

4.2 Price Multiples

  • 1COV's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. 1COV is more expensive than 69.12% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17
1COV.DE Per share data1COV.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • 1COV's earnings are expected to grow with 43.15% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y53.83%
EPS Next 3Y43.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1COV.DE Dividend Analysis

5.1 Amount

  • No dividends for 1COV!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1COV.DE Fundamentals: All Metrics, Ratios and Statistics

COVESTRO AG

FRA:1COV (12/22/2025, 7:00:00 PM)

59.98

+0.18 (+0.3%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-30
Earnings (Next)02-26
Inst Owners9.69%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap11.34B
Revenue(TTM)13.40B
Net Income(TTM)-458.00M
Analysts49.47
Price Target62.53 (4.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0.01
Dividend Growth(5Y)-70.61%
DP-0.22%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-69.67%
Min EPS beat(2)-139.31%
Max EPS beat(2)-0.04%
EPS beat(4)0
Avg EPS beat(4)-380.46%
Min EPS beat(4)-1222.75%
Max EPS beat(4)-0.04%
EPS beat(8)1
Avg EPS beat(8)-4244%
EPS beat(12)2
Avg EPS beat(12)-2876.36%
EPS beat(16)3
Avg EPS beat(16)-2162.14%
Revenue beat(2)0
Avg Revenue beat(2)-4.63%
Min Revenue beat(2)-6.91%
Max Revenue beat(2)-2.34%
Revenue beat(4)0
Avg Revenue beat(4)-4.71%
Min Revenue beat(4)-6.91%
Max Revenue beat(4)-2.34%
Revenue beat(8)0
Avg Revenue beat(8)-4.43%
Revenue beat(12)0
Avg Revenue beat(12)-4.49%
Revenue beat(16)3
Avg Revenue beat(16)-2.5%
PT rev (1m)0.82%
PT rev (3m)0.88%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.92%
EPS NY rev (1m)-6.62%
EPS NY rev (3m)-31.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-8.71%
Revenue NY rev (1m)-0.44%
Revenue NY rev (3m)-0.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 115.3
P/S 0.85
P/FCF N/A
P/OCF 14.21
P/B 1.86
P/tB 2.29
EV/EBITDA 17
EPS(TTM)-2.43
EYN/A
EPS(NY)0.52
Fwd EY0.87%
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)4.22
OCFY7.04%
SpS70.92
BVpS32.22
TBVpS26.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -3.46%
ROE -7.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 13.93%
FCFM N/A
ROA(3y)-1.76%
ROA(5y)1.73%
ROE(3y)-3.61%
ROE(5y)3.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)1.42%
ROCE(5y)6.03%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-78.51%
OM growth 5Y-54.06%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-18%
GM growth 5Y-7.1%
F-Score3
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF N/A
Debt/EBITDA 2.47
Cap/Depr 92.05%
Cap/Sales 6.83%
Interest Coverage N/A
Cash Conversion 95%
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 0.73
Altman-Z 2.27
F-Score3
WACC6.37%
ROIC/WACCN/A
Cap/Depr(3y)75.52%
Cap/Depr(5y)82.02%
Cap/Sales(3y)5.15%
Cap/Sales(5y)5.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-247.06%
EPS Next Y-40.99%
EPS Next 2Y53.83%
EPS Next 3Y43.15%
EPS Next 5Y20.37%
Revenue 1Y (TTM)-5.27%
Revenue growth 3Y-3.75%
Revenue growth 5Y2.7%
Sales Q2Q%-11.99%
Revenue Next Year-7.78%
Revenue Next 2Y-2.6%
Revenue Next 3Y-0.49%
Revenue Next 5Y1.1%
EBIT growth 1Y-220.31%
EBIT growth 3Y-79.32%
EBIT growth 5Y-52.83%
EBIT Next Year238.79%
EBIT Next 3Y78.95%
EBIT Next 5Y42.34%
FCF growth 1Y-116.5%
FCF growth 3Y-60.36%
FCF growth 5Y-28.37%
OCF growth 1Y-45.3%
OCF growth 3Y-26.52%
OCF growth 5Y-8.84%

COVESTRO AG / 1COV.DE Fundamental Analysis FAQ

What is the fundamental rating for 1COV stock?

ChartMill assigns a fundamental rating of 2 / 10 to 1COV.DE.


Can you provide the valuation status for COVESTRO AG?

ChartMill assigns a valuation rating of 1 / 10 to COVESTRO AG (1COV.DE). This can be considered as Overvalued.


What is the profitability of 1COV stock?

COVESTRO AG (1COV.DE) has a profitability rating of 1 / 10.


What is the financial health of COVESTRO AG (1COV.DE) stock?

The financial health rating of COVESTRO AG (1COV.DE) is 3 / 10.


Is the dividend of COVESTRO AG sustainable?

The dividend rating of COVESTRO AG (1COV.DE) is 0 / 10 and the dividend payout ratio is -0.22%.